Detecting Transitional Cell Carcinoma From Haematuria
NCT03256877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750
Last updated 2019-07-29
Summary
To validate ELISAs for the detection of urinary tissue factor (TF) in patients suspected of having bladder cancer.
Conditions
- Transitional Cell Carcinoma
Sponsors & Collaborators
-
C-Term Diagnostics Ltd
collaborator UNKNOWN -
Hull York Medical School
collaborator UNKNOWN -
Hull University Teaching Hospitals NHS Trust
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-18
- Primary Completion
- 2018-05-28
- Completion
- 2019-05-16
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
NCT03193515 ·Status: RECRUITING
-
Detection of Disease in the Upper Tract
NCT05349812 ·Status: WITHDRAWN
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
NCT03193528 ·Status: ACTIVE_NOT_RECRUITING
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Longitudinal Bladder Cancer Study for Tumour Recurrence
NCT05080998 ·Status: RECRUITING
-
Molecular Analysis Of Bladder Cancer
NCT00871754 ·Status: ACTIVE_NOT_RECRUITING
-
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
NCT02700464 ·Status: COMPLETED ·Phase: NA
-
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma
NCT03673202 ·Status: UNKNOWN
-
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05982561 ·Status: RECRUITING
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN
-
High Resolution Imaging for Early and Better Detection of Bladder Cancer
NCT02340650 ·Status: COMPLETED
-
Urine Cytology and Utility in Bladder Recurrence
NCT00971256 ·Status: COMPLETED
-
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
NCT01563796 ·Status: TERMINATED
-
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
NCT03125460 ·Status: COMPLETED
-
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
NCT02735512 ·Status: TERMINATED
-
Bladder EpiCheck European Haematuria Study
NCT06818136 ·Status: RECRUITING
-
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health
NCT00776178 ·Status: COMPLETED
-
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
NCT04310813 ·Status: COMPLETED
-
Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy
NCT02345473 ·Status: COMPLETED
-
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
NCT02647112 ·Status: COMPLETED ·Phase: NA
-
Bladder Cancer Screening Trial
NCT05646485 ·Status: RECRUITING ·Phase: NA
-
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
NCT06525571 ·Status: RECRUITING ·Phase: PHASE3
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING